Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Non-Current Receivables: 2018-2021

  • Genmab A's Non-Current Receivables fell 56.07% to $288.43 in Q2 2021 from the same period last year, while for Jun 2021 it was $288.43, marking a year-over-year decrease of 56.07%. This contributed to the annual value of $276.4 million for FY2020, which is 9.42% down from last year.
  • According to the latest figures from Q2 2021, Genmab A's Non-Current Receivables is $288.43, which was down 100.00% from $276.4 million recorded in Q4 2020.
  • Genmab A's Non-Current Receivables' 5-year high stood at $305.1 million during Q4 2019, with a 5-year trough of $288.43 in Q2 2021.
  • In the last 3 years, Genmab A's Non-Current Receivables had a median value of $91.1 million in 2019 and averaged $134.5 million.
  • Per our database at Business Quant, Genmab A's Non-Current Receivables surged by 107.98% in 2019 and then crashed by 100.00% in 2020.
  • Over the past 4 years, Genmab A's Non-Current Receivables (Quarterly) stood at $146.7 million in 2018, then spiked by 107.98% to $305.1 million in 2019, then fell by 9.42% to $276.4 million in 2020, then tumbled by 56.07% to $288.43 in 2021.
  • Its Non-Current Receivables stands at $288.43 for Q2 2021, versus $276.4 million for Q4 2020 and $656.58 for Q2 2020.